PBMs Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
20:43
Jan 15
Jan 15
PBMs face rising U.S. regulatory scrutiny
She says PBM reform is a bigger healthcare issue than headline drug pricing. PBMs are vertically integrated middlemen between insurers and pharmacies that put small pharmacies out of business, dictate competitor pricing, lack transparency, and have increased profits 230% while premiums rise despite taxpayer subsidies. Ways and Means will question health insurance executives who also own PBMs, creating regulatory and reputational risk for the PBM sector.
HIGH
About PBMs Investor Commentary
Across the available history and selected sources, Buzzberg tracks PBMs across 1 sources: 0 bullish vs 0 bearish calls from 1 authors. Historical directional balance: 0% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 1 total trade idea tracked. Latest voices: Nicole Malliotakis.